Get your

EitrPharma is your dedicated partner for market approach and access to the Nordics for your pharmaceutical and medicinal products

to market faster

Unlocking Market Access Opportunities in the Nordics

You didn’t come this far to stop.

Intelligent market approach

Before you can start pharma market acces it is important to evaluate the national market to see if your pharmaceutical product is ready for use. We use data backed models and clinical insight to help you in your market discovery

#1

Pharma market access made easy

So you have decided that the Nordics is a great place to sell your product, great!
Now we have to engage in market access, including price negiotiation, reimbursement strategies etc. to set your product up for success!

#2

Your pharma parter for success in Norway

Your pharma partner for success

#3

So you have a marketing authorisation for your product, negotiated prices, reimbursements etc. Now it is all smooth sailing, right? Here comes the hardest part, to make sure doctors and other stakeholder receive accurate information about your product

Maximize Market Access in Nordics with a Trusted Pharma Partner

How is it different?

Clinical treatment tradition

The Nordics boasts a longstanding tradition in clinical treatment, emphasizing cost-effective approaches. This legacy is anchored in the clinical guidelines developed by the Association of Doctors, crafted specifically by and for clinicians. Navigating this well-established clinical landscape can pose challenges, particularly in evaluating the feasibility and profitability of entering the market.

NORDIC PHARMACEUTIAL MARKET

Economic and political factors

The Nordics health care system, built on universal access, decentralization, and free choice of providers, is funded through taxes, employee/employer contributions, and co-payments, and is covered by the National Insurance Scheme (NIS). Health care policy is centrally managed, but local authorities handle primary health care based on local needs. The government oversees hospitals, predominantly public, with few private ones mostly publicly funded. Citizens choose their GPs, who are key to accessing specialized care. The Ministry of Health and Care Services, along with the Norwegian Medicines Agency, oversees medicine regulation and reimbursement. Most major international pharma companies operate in Norway, with three main wholesalers and pharmacy chains dispensing medicines, including limited OTC sales in grocery and gas stations.